Colorectal cancer patients to have free test to decide optimal treatment plan
Posted Oct 03 2011 7:11am
Merck Serono have announced that all colorectal cancerAbnormal, uncontrolled cell division resulting in a malignant tumour that may invade surrounding tissues or spread to distant parts of the body. patients in the UK will now have access to a free KRAS biomarker test due to additional funding made available by the company.
The test, which will now be available through the NHS, is hoped to be able to speed up treatment decisions for patients going on to develop secondary (metastatic colorectal cancer). By understanding an individual’s biomarkersA substance that can be measured to help healthcare professionals to assess normal processes, disease processes or a person's response to treatment. in the KRAS test enables their doctors to personalise their treatment plan in the aim of prolonging their life. The test, which until now was only available for metastatic patients, will now allow both primary and secondary bowelA common name for the large and/or small intestines. cancer treatments to become specialised earlier ensuring that patients will receive the right type of medication for them.